Irinotecan and temozolomide combined with dasatinib and rapamycin for patients with relapsed or refractory neuroblastoma: Results of the prospective randomized RIST trial

Corbacioglu, Selim and Lode, Holger N. and Jakob, Marcus and Suttorp, Meinolf and Escherich, Gabriele and Gruhn, Bernd and Ellinger, Susanne and Simon, Thorsten and Lang, Peter and Rohde, Marius and Zeman, Florian and Debatin, Klaus-Michael and Beilken, Andreas and Heiss, Peter and Hellwig, Dirk and Riemenschneider, Markus and Ladenstein, Ruth Lydia and Bochennek, Konrad and Eggert, Angelika and Foell, Juergen (2023) Irinotecan and temozolomide combined with dasatinib and rapamycin for patients with relapsed or refractory neuroblastoma: Results of the prospective randomized RIST trial. In: Annual Meeting of the American Society of Clinical Oncology (ASCO), June 02-06, 2023, Chicago, IL.

Full text not available from this repository.
Item Type: Conference or Workshop Item (Speech)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Abteilung für Pädiatrische Hämatologie, Onkologie und Stammzelltransplantation
Medicine > Abteilung für Neuropathologie
Medicine > Lehrstuhl für Röntgendiagnostik
Medicine > Abteilung für Nuklearmedizin
Medicine > Zentren des Universitätsklinikums Regensburg > Zentrum für Klinische Studien
Depositing User: Dr. Gernot Deinzer
Date Deposited: 08 Mar 2024 10:01
Last Modified: 08 Mar 2024 10:01
URI: https://pred.uni-regensburg.de/id/eprint/59707

Actions (login required)

View Item View Item